CANCER MED-US 润色咨询

Cancer Medicine

出版年份:暂无数据 年文章数:4593 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:1.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2195938, encodeId=78f5219593880, content=修回review 完到了pending decision 阶段,大家知道需要多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2aca90523, createdName=zh123, createdTime=Thu Mar 28 21:17:38 CST 2024, time=9小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122115, encodeId=29ff21221156c, content=Major revision后Pending rommendation一周了,大家到decision一般多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Mon Mar 27 20:15:10 CST 2023, time=2023-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194207, encodeId=a9c4219420ee1, content=有没有同仁们知道转投的稿件会比一般的稿件处理更快吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Wed Mar 20 08:54:13 CST 2024, time=2024-03-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2195703, encodeId=7b412195e0332, content=wb需要整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Wed Mar 27 19:05:57 CST 2024, time=2024-03-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2183237, encodeId=921f218323e1c, content=审稿速度:6.0<br>偏重的研究方向:食管;肿瘤<br>经验分享:2023.9.3投搞的,到2024.1.22还是under review,催过3次,只回复了一次,但是依然没有进展,为什么这个杂志这么慢,着急毕业党真的等不起了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0feb8578914, createdName=ms2000001037572145, createdTime=Mon Jan 22 16:28:43 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2194765, encodeId=413f2194e65f7, content=这个杂志很慢,我投稿23年9月,到24年3月才返修,修回5天还没消息,不知道又要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05288777948, createdName=ms9000001944740404, createdTime=Fri Mar 22 19:02:29 CST 2024, time=2024-03-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2194624, encodeId=31c52194624ab, content=可以聊聊,周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Fri Mar 22 09:21:58 CST 2024, time=2024-03-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:一审4个月,修回后2个多月还没还没结果。<br>这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194384, encodeId=8f79219438457, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:大修后送外审,一个半月审回,直接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66798639657, createdName=ms9000002120902847, createdTime=Thu Mar 21 01:20:25 CST 2024, time=2024-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174369, encodeId=5dc121e4369fa, content=偏重的研究方向:生物信息学;肿瘤;生物标志物<br>经验分享:请问大家接收后多久proof啊,我这都快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dda18523295, createdName=ms5000000694299261, createdTime=Tue Dec 12 01:27:46 CST 2023, time=2023-12-12, status=1, ipAttribution=天津)]
    9小时前 zh123 来自广东省

    修回review 完到了pending decision 阶段,大家知道需要多久吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2195938, encodeId=78f5219593880, content=修回review 完到了pending decision 阶段,大家知道需要多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2aca90523, createdName=zh123, createdTime=Thu Mar 28 21:17:38 CST 2024, time=9小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122115, encodeId=29ff21221156c, content=Major revision后Pending rommendation一周了,大家到decision一般多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Mon Mar 27 20:15:10 CST 2023, time=2023-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194207, encodeId=a9c4219420ee1, content=有没有同仁们知道转投的稿件会比一般的稿件处理更快吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Wed Mar 20 08:54:13 CST 2024, time=2024-03-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2195703, encodeId=7b412195e0332, content=wb需要整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Wed Mar 27 19:05:57 CST 2024, time=2024-03-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2183237, encodeId=921f218323e1c, content=审稿速度:6.0<br>偏重的研究方向:食管;肿瘤<br>经验分享:2023.9.3投搞的,到2024.1.22还是under review,催过3次,只回复了一次,但是依然没有进展,为什么这个杂志这么慢,着急毕业党真的等不起了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0feb8578914, createdName=ms2000001037572145, createdTime=Mon Jan 22 16:28:43 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2194765, encodeId=413f2194e65f7, content=这个杂志很慢,我投稿23年9月,到24年3月才返修,修回5天还没消息,不知道又要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05288777948, createdName=ms9000001944740404, createdTime=Fri Mar 22 19:02:29 CST 2024, time=2024-03-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2194624, encodeId=31c52194624ab, content=可以聊聊,周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Fri Mar 22 09:21:58 CST 2024, time=2024-03-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:一审4个月,修回后2个多月还没还没结果。<br>这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194384, encodeId=8f79219438457, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:大修后送外审,一个半月审回,直接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66798639657, createdName=ms9000002120902847, createdTime=Thu Mar 21 01:20:25 CST 2024, time=2024-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174369, encodeId=5dc121e4369fa, content=偏重的研究方向:生物信息学;肿瘤;生物标志物<br>经验分享:请问大家接收后多久proof啊,我这都快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dda18523295, createdName=ms5000000694299261, createdTime=Tue Dec 12 01:27:46 CST 2023, time=2023-12-12, status=1, ipAttribution=天津)]
    2023-03-27 ms1000000302991030 来自浙江省

    Major revision后Pending rommendation一周了,大家到decision一般多久?

    7

    展开7条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2195938, encodeId=78f5219593880, content=修回review 完到了pending decision 阶段,大家知道需要多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2aca90523, createdName=zh123, createdTime=Thu Mar 28 21:17:38 CST 2024, time=9小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122115, encodeId=29ff21221156c, content=Major revision后Pending rommendation一周了,大家到decision一般多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Mon Mar 27 20:15:10 CST 2023, time=2023-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194207, encodeId=a9c4219420ee1, content=有没有同仁们知道转投的稿件会比一般的稿件处理更快吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Wed Mar 20 08:54:13 CST 2024, time=2024-03-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2195703, encodeId=7b412195e0332, content=wb需要整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Wed Mar 27 19:05:57 CST 2024, time=2024-03-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2183237, encodeId=921f218323e1c, content=审稿速度:6.0<br>偏重的研究方向:食管;肿瘤<br>经验分享:2023.9.3投搞的,到2024.1.22还是under review,催过3次,只回复了一次,但是依然没有进展,为什么这个杂志这么慢,着急毕业党真的等不起了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0feb8578914, createdName=ms2000001037572145, createdTime=Mon Jan 22 16:28:43 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2194765, encodeId=413f2194e65f7, content=这个杂志很慢,我投稿23年9月,到24年3月才返修,修回5天还没消息,不知道又要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05288777948, createdName=ms9000001944740404, createdTime=Fri Mar 22 19:02:29 CST 2024, time=2024-03-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2194624, encodeId=31c52194624ab, content=可以聊聊,周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Fri Mar 22 09:21:58 CST 2024, time=2024-03-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:一审4个月,修回后2个多月还没还没结果。<br>这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194384, encodeId=8f79219438457, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:大修后送外审,一个半月审回,直接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66798639657, createdName=ms9000002120902847, createdTime=Thu Mar 21 01:20:25 CST 2024, time=2024-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174369, encodeId=5dc121e4369fa, content=偏重的研究方向:生物信息学;肿瘤;生物标志物<br>经验分享:请问大家接收后多久proof啊,我这都快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dda18523295, createdName=ms5000000694299261, createdTime=Tue Dec 12 01:27:46 CST 2023, time=2023-12-12, status=1, ipAttribution=天津)]
    2024-03-20 ms9000002054407114 来自河北省

    有没有同仁们知道转投的稿件会比一般的稿件处理更快吗?

    4

    展开4条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2195938, encodeId=78f5219593880, content=修回review 完到了pending decision 阶段,大家知道需要多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2aca90523, createdName=zh123, createdTime=Thu Mar 28 21:17:38 CST 2024, time=9小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122115, encodeId=29ff21221156c, content=Major revision后Pending rommendation一周了,大家到decision一般多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Mon Mar 27 20:15:10 CST 2023, time=2023-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194207, encodeId=a9c4219420ee1, content=有没有同仁们知道转投的稿件会比一般的稿件处理更快吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Wed Mar 20 08:54:13 CST 2024, time=2024-03-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2195703, encodeId=7b412195e0332, content=wb需要整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Wed Mar 27 19:05:57 CST 2024, time=2024-03-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2183237, encodeId=921f218323e1c, content=审稿速度:6.0<br>偏重的研究方向:食管;肿瘤<br>经验分享:2023.9.3投搞的,到2024.1.22还是under review,催过3次,只回复了一次,但是依然没有进展,为什么这个杂志这么慢,着急毕业党真的等不起了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0feb8578914, createdName=ms2000001037572145, createdTime=Mon Jan 22 16:28:43 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2194765, encodeId=413f2194e65f7, content=这个杂志很慢,我投稿23年9月,到24年3月才返修,修回5天还没消息,不知道又要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05288777948, createdName=ms9000001944740404, createdTime=Fri Mar 22 19:02:29 CST 2024, time=2024-03-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2194624, encodeId=31c52194624ab, content=可以聊聊,周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Fri Mar 22 09:21:58 CST 2024, time=2024-03-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:一审4个月,修回后2个多月还没还没结果。<br>这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194384, encodeId=8f79219438457, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:大修后送外审,一个半月审回,直接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66798639657, createdName=ms9000002120902847, createdTime=Thu Mar 21 01:20:25 CST 2024, time=2024-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174369, encodeId=5dc121e4369fa, content=偏重的研究方向:生物信息学;肿瘤;生物标志物<br>经验分享:请问大家接收后多久proof啊,我这都快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dda18523295, createdName=ms5000000694299261, createdTime=Tue Dec 12 01:27:46 CST 2023, time=2023-12-12, status=1, ipAttribution=天津)]
    2024-03-27 ms3000001126828781 来自广西

    wb需要整膜吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2195938, encodeId=78f5219593880, content=修回review 完到了pending decision 阶段,大家知道需要多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2aca90523, createdName=zh123, createdTime=Thu Mar 28 21:17:38 CST 2024, time=9小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122115, encodeId=29ff21221156c, content=Major revision后Pending rommendation一周了,大家到decision一般多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Mon Mar 27 20:15:10 CST 2023, time=2023-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194207, encodeId=a9c4219420ee1, content=有没有同仁们知道转投的稿件会比一般的稿件处理更快吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Wed Mar 20 08:54:13 CST 2024, time=2024-03-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2195703, encodeId=7b412195e0332, content=wb需要整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Wed Mar 27 19:05:57 CST 2024, time=2024-03-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2183237, encodeId=921f218323e1c, content=审稿速度:6.0<br>偏重的研究方向:食管;肿瘤<br>经验分享:2023.9.3投搞的,到2024.1.22还是under review,催过3次,只回复了一次,但是依然没有进展,为什么这个杂志这么慢,着急毕业党真的等不起了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0feb8578914, createdName=ms2000001037572145, createdTime=Mon Jan 22 16:28:43 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2194765, encodeId=413f2194e65f7, content=这个杂志很慢,我投稿23年9月,到24年3月才返修,修回5天还没消息,不知道又要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05288777948, createdName=ms9000001944740404, createdTime=Fri Mar 22 19:02:29 CST 2024, time=2024-03-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2194624, encodeId=31c52194624ab, content=可以聊聊,周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Fri Mar 22 09:21:58 CST 2024, time=2024-03-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:一审4个月,修回后2个多月还没还没结果。<br>这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194384, encodeId=8f79219438457, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:大修后送外审,一个半月审回,直接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66798639657, createdName=ms9000002120902847, createdTime=Thu Mar 21 01:20:25 CST 2024, time=2024-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174369, encodeId=5dc121e4369fa, content=偏重的研究方向:生物信息学;肿瘤;生物标志物<br>经验分享:请问大家接收后多久proof啊,我这都快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dda18523295, createdName=ms5000000694299261, createdTime=Tue Dec 12 01:27:46 CST 2023, time=2023-12-12, status=1, ipAttribution=天津)]
    2024-01-22 ms2000001037572145 来自北京

    审稿速度:6.0
    偏重的研究方向:食管;肿瘤
    经验分享:2023.9.3投搞的,到2024.1.22还是under review,催过3次,只回复了一次,但是依然没有进展,为什么这个杂志这么慢,着急毕业党真的等不起了啊

    7

    展开7条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2195938, encodeId=78f5219593880, content=修回review 完到了pending decision 阶段,大家知道需要多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2aca90523, createdName=zh123, createdTime=Thu Mar 28 21:17:38 CST 2024, time=9小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122115, encodeId=29ff21221156c, content=Major revision后Pending rommendation一周了,大家到decision一般多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Mon Mar 27 20:15:10 CST 2023, time=2023-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194207, encodeId=a9c4219420ee1, content=有没有同仁们知道转投的稿件会比一般的稿件处理更快吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Wed Mar 20 08:54:13 CST 2024, time=2024-03-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2195703, encodeId=7b412195e0332, content=wb需要整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Wed Mar 27 19:05:57 CST 2024, time=2024-03-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2183237, encodeId=921f218323e1c, content=审稿速度:6.0<br>偏重的研究方向:食管;肿瘤<br>经验分享:2023.9.3投搞的,到2024.1.22还是under review,催过3次,只回复了一次,但是依然没有进展,为什么这个杂志这么慢,着急毕业党真的等不起了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0feb8578914, createdName=ms2000001037572145, createdTime=Mon Jan 22 16:28:43 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2194765, encodeId=413f2194e65f7, content=这个杂志很慢,我投稿23年9月,到24年3月才返修,修回5天还没消息,不知道又要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05288777948, createdName=ms9000001944740404, createdTime=Fri Mar 22 19:02:29 CST 2024, time=2024-03-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2194624, encodeId=31c52194624ab, content=可以聊聊,周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Fri Mar 22 09:21:58 CST 2024, time=2024-03-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:一审4个月,修回后2个多月还没还没结果。<br>这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194384, encodeId=8f79219438457, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:大修后送外审,一个半月审回,直接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66798639657, createdName=ms9000002120902847, createdTime=Thu Mar 21 01:20:25 CST 2024, time=2024-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174369, encodeId=5dc121e4369fa, content=偏重的研究方向:生物信息学;肿瘤;生物标志物<br>经验分享:请问大家接收后多久proof啊,我这都快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dda18523295, createdName=ms5000000694299261, createdTime=Tue Dec 12 01:27:46 CST 2023, time=2023-12-12, status=1, ipAttribution=天津)]
    2024-03-22 ms9000001944740404 来自河南省

    这个杂志很慢,我投稿23年9月,到24年3月才返修,修回5天还没消息,不知道又要等多久

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2195938, encodeId=78f5219593880, content=修回review 完到了pending decision 阶段,大家知道需要多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2aca90523, createdName=zh123, createdTime=Thu Mar 28 21:17:38 CST 2024, time=9小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122115, encodeId=29ff21221156c, content=Major revision后Pending rommendation一周了,大家到decision一般多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Mon Mar 27 20:15:10 CST 2023, time=2023-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194207, encodeId=a9c4219420ee1, content=有没有同仁们知道转投的稿件会比一般的稿件处理更快吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Wed Mar 20 08:54:13 CST 2024, time=2024-03-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2195703, encodeId=7b412195e0332, content=wb需要整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Wed Mar 27 19:05:57 CST 2024, time=2024-03-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2183237, encodeId=921f218323e1c, content=审稿速度:6.0<br>偏重的研究方向:食管;肿瘤<br>经验分享:2023.9.3投搞的,到2024.1.22还是under review,催过3次,只回复了一次,但是依然没有进展,为什么这个杂志这么慢,着急毕业党真的等不起了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0feb8578914, createdName=ms2000001037572145, createdTime=Mon Jan 22 16:28:43 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2194765, encodeId=413f2194e65f7, content=这个杂志很慢,我投稿23年9月,到24年3月才返修,修回5天还没消息,不知道又要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05288777948, createdName=ms9000001944740404, createdTime=Fri Mar 22 19:02:29 CST 2024, time=2024-03-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2194624, encodeId=31c52194624ab, content=可以聊聊,周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Fri Mar 22 09:21:58 CST 2024, time=2024-03-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:一审4个月,修回后2个多月还没还没结果。<br>这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194384, encodeId=8f79219438457, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:大修后送外审,一个半月审回,直接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66798639657, createdName=ms9000002120902847, createdTime=Thu Mar 21 01:20:25 CST 2024, time=2024-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174369, encodeId=5dc121e4369fa, content=偏重的研究方向:生物信息学;肿瘤;生物标志物<br>经验分享:请问大家接收后多久proof啊,我这都快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dda18523295, createdName=ms5000000694299261, createdTime=Tue Dec 12 01:27:46 CST 2023, time=2023-12-12, status=1, ipAttribution=天津)]
    2024-03-22 零零一 来自广西

    可以聊聊,周期也就两三个月

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2195938, encodeId=78f5219593880, content=修回review 完到了pending decision 阶段,大家知道需要多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2aca90523, createdName=zh123, createdTime=Thu Mar 28 21:17:38 CST 2024, time=9小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122115, encodeId=29ff21221156c, content=Major revision后Pending rommendation一周了,大家到decision一般多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Mon Mar 27 20:15:10 CST 2023, time=2023-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194207, encodeId=a9c4219420ee1, content=有没有同仁们知道转投的稿件会比一般的稿件处理更快吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Wed Mar 20 08:54:13 CST 2024, time=2024-03-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2195703, encodeId=7b412195e0332, content=wb需要整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Wed Mar 27 19:05:57 CST 2024, time=2024-03-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2183237, encodeId=921f218323e1c, content=审稿速度:6.0<br>偏重的研究方向:食管;肿瘤<br>经验分享:2023.9.3投搞的,到2024.1.22还是under review,催过3次,只回复了一次,但是依然没有进展,为什么这个杂志这么慢,着急毕业党真的等不起了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0feb8578914, createdName=ms2000001037572145, createdTime=Mon Jan 22 16:28:43 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2194765, encodeId=413f2194e65f7, content=这个杂志很慢,我投稿23年9月,到24年3月才返修,修回5天还没消息,不知道又要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05288777948, createdName=ms9000001944740404, createdTime=Fri Mar 22 19:02:29 CST 2024, time=2024-03-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2194624, encodeId=31c52194624ab, content=可以聊聊,周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Fri Mar 22 09:21:58 CST 2024, time=2024-03-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:一审4个月,修回后2个多月还没还没结果。<br>这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194384, encodeId=8f79219438457, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:大修后送外审,一个半月审回,直接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66798639657, createdName=ms9000002120902847, createdTime=Thu Mar 21 01:20:25 CST 2024, time=2024-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174369, encodeId=5dc121e4369fa, content=偏重的研究方向:生物信息学;肿瘤;生物标志物<br>经验分享:请问大家接收后多久proof啊,我这都快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dda18523295, createdName=ms5000000694299261, createdTime=Tue Dec 12 01:27:46 CST 2023, time=2023-12-12, status=1, ipAttribution=天津)]
    2024-03-21 ms1000001834918815 来自浙江省

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享:一审4个月,修回后2个多月还没还没结果。
    这个期刊太慢了

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2195938, encodeId=78f5219593880, content=修回review 完到了pending decision 阶段,大家知道需要多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2aca90523, createdName=zh123, createdTime=Thu Mar 28 21:17:38 CST 2024, time=9小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122115, encodeId=29ff21221156c, content=Major revision后Pending rommendation一周了,大家到decision一般多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Mon Mar 27 20:15:10 CST 2023, time=2023-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194207, encodeId=a9c4219420ee1, content=有没有同仁们知道转投的稿件会比一般的稿件处理更快吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Wed Mar 20 08:54:13 CST 2024, time=2024-03-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2195703, encodeId=7b412195e0332, content=wb需要整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Wed Mar 27 19:05:57 CST 2024, time=2024-03-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2183237, encodeId=921f218323e1c, content=审稿速度:6.0<br>偏重的研究方向:食管;肿瘤<br>经验分享:2023.9.3投搞的,到2024.1.22还是under review,催过3次,只回复了一次,但是依然没有进展,为什么这个杂志这么慢,着急毕业党真的等不起了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0feb8578914, createdName=ms2000001037572145, createdTime=Mon Jan 22 16:28:43 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2194765, encodeId=413f2194e65f7, content=这个杂志很慢,我投稿23年9月,到24年3月才返修,修回5天还没消息,不知道又要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05288777948, createdName=ms9000001944740404, createdTime=Fri Mar 22 19:02:29 CST 2024, time=2024-03-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2194624, encodeId=31c52194624ab, content=可以聊聊,周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Fri Mar 22 09:21:58 CST 2024, time=2024-03-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:一审4个月,修回后2个多月还没还没结果。<br>这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194384, encodeId=8f79219438457, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:大修后送外审,一个半月审回,直接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66798639657, createdName=ms9000002120902847, createdTime=Thu Mar 21 01:20:25 CST 2024, time=2024-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174369, encodeId=5dc121e4369fa, content=偏重的研究方向:生物信息学;肿瘤;生物标志物<br>经验分享:请问大家接收后多久proof啊,我这都快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dda18523295, createdName=ms5000000694299261, createdTime=Tue Dec 12 01:27:46 CST 2023, time=2023-12-12, status=1, ipAttribution=天津)]
    2024-03-21 ms9000002120902847 来自广东省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:肿瘤学
    经验分享:大修后送外审,一个半月审回,直接accept

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2195938, encodeId=78f5219593880, content=修回review 完到了pending decision 阶段,大家知道需要多久吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2aca90523, createdName=zh123, createdTime=Thu Mar 28 21:17:38 CST 2024, time=9小时前, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122115, encodeId=29ff21221156c, content=Major revision后Pending rommendation一周了,大家到decision一般多久?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=096b5509530, createdName=ms1000000302991030, createdTime=Mon Mar 27 20:15:10 CST 2023, time=2023-03-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194207, encodeId=a9c4219420ee1, content=有没有同仁们知道转投的稿件会比一般的稿件处理更快吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe768803134, createdName=ms9000002054407114, createdTime=Wed Mar 20 08:54:13 CST 2024, time=2024-03-20, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2195703, encodeId=7b412195e0332, content=wb需要整膜吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=99d78274978, createdName=ms3000001126828781, createdTime=Wed Mar 27 19:05:57 CST 2024, time=2024-03-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2183237, encodeId=921f218323e1c, content=审稿速度:6.0<br>偏重的研究方向:食管;肿瘤<br>经验分享:2023.9.3投搞的,到2024.1.22还是under review,催过3次,只回复了一次,但是依然没有进展,为什么这个杂志这么慢,着急毕业党真的等不起了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0feb8578914, createdName=ms2000001037572145, createdTime=Mon Jan 22 16:28:43 CST 2024, time=2024-01-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2194765, encodeId=413f2194e65f7, content=这个杂志很慢,我投稿23年9月,到24年3月才返修,修回5天还没消息,不知道又要等多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=05288777948, createdName=ms9000001944740404, createdTime=Fri Mar 22 19:02:29 CST 2024, time=2024-03-22, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2194624, encodeId=31c52194624ab, content=可以聊聊,周期也就两三个月, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202403/72312163c68e4099952942b04fa6f369-k56lKDLhTfUF.jpg, createdBy=39cc9222865, createdName=零零一, createdTime=Fri Mar 22 09:21:58 CST 2024, time=2024-03-22, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2194570, encodeId=fd7c21945e0a1, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享:一审4个月,修回后2个多月还没还没结果。<br>这个期刊太慢了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=112d5638756, createdName=ms1000001834918815, createdTime=Thu Mar 21 21:49:48 CST 2024, time=2024-03-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2194384, encodeId=8f79219438457, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:肿瘤学<br>经验分享:大修后送外审,一个半月审回,直接accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66798639657, createdName=ms9000002120902847, createdTime=Thu Mar 21 01:20:25 CST 2024, time=2024-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174369, encodeId=5dc121e4369fa, content=偏重的研究方向:生物信息学;肿瘤;生物标志物<br>经验分享:请问大家接收后多久proof啊,我这都快3个月了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dda18523295, createdName=ms5000000694299261, createdTime=Tue Dec 12 01:27:46 CST 2023, time=2023-12-12, status=1, ipAttribution=天津)]
    2023-12-12 ms5000000694299261 来自天津

    偏重的研究方向:生物信息学;肿瘤;生物标志物
    经验分享:请问大家接收后多久proof啊,我这都快3个月了

    1

    展开1条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分